UNSPSC 51453502: Nitazoxanide

This classification denotes an antiprotozoal agent with the molecular formula C12H9N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SOA12P041N, chemically known as salicylamide, n-(5-nitro-2-thiazolyl)-, acetate (ester) but generally known as nitazoxanide, which bears US NIH Compound Identifier 41684. European Medicines Agency schedules Nitazoxanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09311MIG.

UNSPSC 51453502 Nitazoxanide (Commodity) represents pharmaceutical products acquired by state and local health departments through piggyback purchasing agreements and direct procurement vehicles. The code encompasses specific pharmaceutical active ingredients and formulations that state and local public health agencies procure to support emergency preparedness, disease treatment, and community health initiatives. Recent state and local opportunities under this code show acquisition of pharmaceutical products including antibiotic tablets and emergency medical countermeasures such as naloxone through competitive bidding and cooperative purchasing consortia.

State health departments and county public health authorities are the primary issuing bodies. The Illinois Department of Public Health has awarded multi-year pharmaceutical supply contracts through the MMCAP Infuse consortium, while Seminole County, Florida has solicited naloxone and drug deactivation systems through competitive IFB processes. Recent activity spans Illinois and Florida, with procurement structured around quarterly or annual delivery cycles and initial contract terms of one to three years with renewal options. The Illinois Department of Public Health awarded a $2.999 million piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (solicitation 26482DPHPREPDB53392) for antibiotics including Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an IFB process with a 12-month initial term and two additional renewal years. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries, with a two-year initial term and one-year renewal option; the procurement includes FEMA funding and requires compliance with federal environmental regulations, E-Verify, and standard insurance and workplace certifications.